FI964783A0 - Menetelmä syövän hoitamiseksi p53-proteiinia säätelemällä - Google Patents

Menetelmä syövän hoitamiseksi p53-proteiinia säätelemällä

Info

Publication number
FI964783A0
FI964783A0 FI964783A FI964783A FI964783A0 FI 964783 A0 FI964783 A0 FI 964783A0 FI 964783 A FI964783 A FI 964783A FI 964783 A FI964783 A FI 964783A FI 964783 A0 FI964783 A0 FI 964783A0
Authority
FI
Finland
Prior art keywords
protein
regulation
treating cancer
cancer
treating
Prior art date
Application number
FI964783A
Other languages
English (en)
Swedish (sv)
Other versions
FI964783A (fi
FI120501B (fi
Inventor
Jean-Marie Blanchard
Serge Carillo
Marc Peichaczyk
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI964783A0 publication Critical patent/FI964783A0/fi
Publication of FI964783A publication Critical patent/FI964783A/fi
Application granted granted Critical
Publication of FI120501B publication Critical patent/FI120501B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI964783A 1994-05-31 1996-11-29 p53-proteiinin pitoisuuksia säätelevien kalpaiinin aktiivisuuden inhibiittorien käyttö syöpälääkkeiden valmistuksessa FI120501B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9406583 1994-05-31
FR9406583A FR2720277B1 (fr) 1994-05-31 1994-05-31 Méthode de traitement des cancers par régulation de la protéine P53.
FR9500670 1995-05-22
PCT/FR1995/000670 WO1995033060A1 (fr) 1994-05-31 1995-05-22 Methode de traitement des cancers par regulation de la proteine p53

Publications (3)

Publication Number Publication Date
FI964783A0 true FI964783A0 (fi) 1996-11-29
FI964783A FI964783A (fi) 1996-11-29
FI120501B FI120501B (fi) 2009-11-13

Family

ID=9463670

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964783A FI120501B (fi) 1994-05-31 1996-11-29 p53-proteiinin pitoisuuksia säätelevien kalpaiinin aktiivisuuden inhibiittorien käyttö syöpälääkkeiden valmistuksessa

Country Status (8)

Country Link
EP (1) EP0763121A1 (fi)
JP (1) JPH10500978A (fi)
AU (1) AU714209B2 (fi)
CA (1) CA2190293C (fi)
FI (1) FI120501B (fi)
FR (1) FR2720277B1 (fi)
NO (1) NO321411B1 (fi)
WO (1) WO1995033060A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518488C1 (de) * 1995-05-19 1996-10-10 Progen Biotechnik Gmbh Autoantigen, geeignet zur Feststellung einer Thromboseneigung
EP0799892A3 (en) * 1996-04-05 1998-08-12 Takeda Chemical Industries, Ltd. Calpain, its production and use
US6232454B1 (en) 1998-02-27 2001-05-15 Incyte Genomics, Inc. Human proteinase molecules
AU2344100A (en) * 1998-11-18 2000-06-05 Canji, Inc. Viral vectors with late transgene expression
AU2001247922A1 (en) * 2000-03-31 2001-10-15 Parker Hughes Institute Calpain inhibitors in cancer treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753665B2 (ja) * 1984-04-20 1995-06-07 財団法人癌研究会 抗転移剤
US5340922B1 (en) * 1988-05-31 1999-11-02 Mclean Hospital Corp Neural calcium-activated neutral proteinase inhibitors
EP0395309B1 (en) * 1989-04-28 1995-12-27 Takara Shuzo Co. Ltd. Human calpastatin-like polypeptide
JPH0641067A (ja) * 1992-04-20 1994-02-15 Kitasato Inst:The 新規カルパイン阻害物質ｋｐ−１２４１及びその製造法
EP0580161A1 (en) * 1992-07-22 1994-01-26 THE McLEAN HOSPITAL CORPORATION Prophylactic and therapeutic treatment of Alzheimer's disease
US5607831A (en) * 1993-03-25 1997-03-04 The United States Of America As Represented By The Department Of Health And Human Services In vitro methods for assessing the susceptibility of HIV-1-infected individuals to cysteine protease-mediated activation-induced programmed cell death

Also Published As

Publication number Publication date
NO321411B1 (no) 2006-05-08
AU2620695A (en) 1995-12-21
FI964783A (fi) 1996-11-29
CA2190293C (fr) 2011-06-28
NO964772L (no) 1996-11-11
FI120501B (fi) 2009-11-13
CA2190293A1 (fr) 1995-12-07
NO964772D0 (no) 1996-11-11
JPH10500978A (ja) 1998-01-27
FR2720277B1 (fr) 1996-07-12
EP0763121A1 (fr) 1997-03-19
FR2720277A1 (fr) 1995-12-01
AU714209B2 (en) 1999-12-23
WO1995033060A1 (fr) 1995-12-07

Similar Documents

Publication Publication Date Title
FI970102A (fi) Menetelmä substiuoitujen sulfoksidien syntetisoimiseksi
FI970918A0 (fi) Yhdisteet ja menetelmät syövän hoitamiseksi
FI931657A0 (fi) Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
NO995996D0 (no) Fremgangsmåte for behandling av fedme
FI956290A (fi) Eksimerifluoresenssimenetelmä pinnoitteen kovettamisen määräämiseksi
FI964194A (fi) Laite puolipyöreän kourun valmistamiseksi
FI980853A0 (fi) Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta
FI940316A (fi) Menetelmä heraproteiinien fraktioimiseksi
BR9304004A (pt) Método de tratamento de arrozal
FI964783A0 (fi) Menetelmä syövän hoitamiseksi p53-proteiinia säätelemällä
FI953690A0 (fi) Menetelmä ja laite vedenpoiston tarkkailemiseksi suspensiosta
FI973173A0 (fi) Menetelmä kondensaatin käsittelemiseksi
FI971035A0 (fi) Biokonversioprosessi trans-hydroksisulfonin syntetisoimiseksi
NO981822D0 (no) Anvendelse av proteinet GAX for behandling av cancer
DE69717846D1 (de) Behandlungsverfahren von laktamen
FI980091A0 (fi) Menetelmä ylijäämäaktiivilietteen käsittelemiseksi
FI953170A (fi) Oligunokleotidit isoprenyyliproteiinitransferaasin ilmentämisen inhibiboimiseksi
FI960907A (fi) Menetelmä kuivatustehon säätämiseksi
FI940846A0 (fi) Menetelmä heraproteiinien eristämiseksi
DE69812599D1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
FI970098A0 (fi) Menetelmä ja yhdiste hiustenlähdön hoitamiseksi
DE69706195D1 (de) Antikonvulsive derivate zur behandlung von psoriasis
FI97725B (fi) Menetelmä diltiatseemin valmistamiseksi
FI971964A0 (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS PHARMA S.A.

FG Patent granted

Ref document number: 120501

Country of ref document: FI

MM Patent lapsed